Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
San Diego Cardiac Center, San Diego, California University of California, San Francisco, San Francisco, California Washington University in Saint Louis, St Louis, Missouri University of Texas Southwestern Medical Center, Dallas, Texas University of Washington Medicine, Seattle, Washington